Terms: = Prostate cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
23 results:
1. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
[No Abstract] [Full Text] [Related]
2. Role of RNA binding proteins of the
Takeiwa T; Ikeda K; Horie K; Inoue S
RNA Biol; 2024 Jan; 21(1):1-17. PubMed ID: 38551131
[TBL] [Abstract] [Full Text] [Related]
3. Remodeling oncogenic transcriptomes by small molecules targeting nono.
Kathman SG; Koo SJ; Lindsey GL; Her HL; Blue SM; Li H; Jaensch S; Remsberg JR; Ahn K; Yeo GW; Ghosh B; Cravatt BF
Nat Chem Biol; 2023 Jul; 19(7):825-836. PubMed ID: 36864190
[TBL] [Abstract] [Full Text] [Related]
4. Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistance.
Peng G; Wang C; Wang H; Qu M; Dong K; Yu Y; Jiang Y; Gan S; Gao X
Oncoimmunology; 2023; 12(1):2173422. PubMed ID: 36776524
[TBL] [Abstract] [Full Text] [Related]
5. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
6. Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with
von Eyben FE; Kulkarni HR; Baum RP
Theranostics; 2020; 10(11):4900-4902. PubMed ID: 32308757
[TBL] [Abstract] [Full Text] [Related]
7. Splicing Factors Have an Essential Role in prostate cancer Progression and Androgen Receptor Signaling.
Takayama KI
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30939845
[TBL] [Abstract] [Full Text] [Related]
8. Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
Seabra AB; Durán N
Eur J Pharmacol; 2018 May; 826():158-168. PubMed ID: 29501865
[TBL] [Abstract] [Full Text] [Related]
9. nono ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer.
Alfano L; Caporaso A; Altieri A; Costa C; Forte IM; Iannuzzi CA; Barone D; Esposito L; Giordano A; Pentimalli F
J Cell Physiol; 2018 May; 233(5):4338-4344. PubMed ID: 29150959
[TBL] [Abstract] [Full Text] [Related]
10. Association of ABO Blood Types and Clinicopathological Features of prostate cancer.
Wang FM; Zhang Y; Zhang GM; Liu YN; Sun LJ; Liu Y
Dis Markers; 2017; 2017():9237481. PubMed ID: 29129952
[TBL] [Abstract] [Full Text] [Related]
11. Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF.
Takayama KI; Suzuki T; Fujimura T; Yamada Y; Takahashi S; Homma Y; Suzuki Y; Inoue S
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10461-10466. PubMed ID: 28893982
[TBL] [Abstract] [Full Text] [Related]
12. S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells.
Amaral CL; Freitas LB; Tamura RE; Tavares MR; Pavan IC; Bajgelman MC; Simabuco FM
BMC Cancer; 2016 Aug; 16():602. PubMed ID: 27491285
[TBL] [Abstract] [Full Text] [Related]
13. Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel nono-TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum.
Wang XT; Xia QY; Ni H; Wang ZY; Ye SB; Li R; Wang X; Lv JH; Shi SS; Ma HH; Lu ZF; Shen Q; Zhou XJ; Rao Q
Histopathology; 2016 Sep; 69(3):450-8. PubMed ID: 26844676
[TBL] [Abstract] [Full Text] [Related]
14. [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
Poncet D; Arnoux V; Descotes JL; Rambeaud JJ; Verry C; Terrier N; Boillot B; Dubreuil J; Lanchon C; Carnicelli D; Fiard G; Long JA
Prog Urol; 2015 May; 25(6):325-30. PubMed ID: 25748788
[TBL] [Abstract] [Full Text] [Related]
15. Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy.
Tollefson MK; Karnes RJ; Rangel L; Carlson R; Boorjian SA
J Urol; 2014 Mar; 191(3):646-51. PubMed ID: 24140843
[TBL] [Abstract] [Full Text] [Related]
16. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
[TBL] [Abstract] [Full Text] [Related]
17. Anti-inflammatory agents as cancer therapeutics.
Kashfi K
Adv Pharmacol; 2009; 57():31-89. PubMed ID: 20230759
[TBL] [Abstract] [Full Text] [Related]
18. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract] [Full Text] [Related]
19. A pp32-retinoblastoma protein complex modulates androgen receptor-mediated transcription and associates with components of the splicing machinery.
Adegbola O; Pasternack GR
Biochem Biophys Res Commun; 2005 Aug; 334(2):702-8. PubMed ID: 16009334
[TBL] [Abstract] [Full Text] [Related]
20. 55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor.
Ishiguro H; Uemura H; Fujinami K; Ikeda N; Ohta S; Kubota Y
Int J Cancer; 2003 May; 105(1):26-32. PubMed ID: 12672026
[TBL] [Abstract] [Full Text] [Related]
[Next]
